Compliance Considerations for Pharmacy Sale or Acquisition

Across all industries, people are changing the ways they engage with products, services, and brands. As a result, life sciences companies find themselves challenged to compete for mindshare in an increasingly noisy market. To stay relevant, pharma marketers must re-evaluate their traditional commercial models and address the changing expectations of their customers—at scale. In this free podcast, Aptus Health in association with PharmaTimes, will explore opportunities pharma marketers have to leverage digital communications to create engaging, high-value experiences for their target markets. We’ll also share examples of how the right technologies and approaches drive meaningful outcomes.

Multiparameter flow cytometry has become an integral tool in the workup of abnormal WBC findings, allowing for rapid and accurate identification of abnormal cell populations, cell lineage assignment, and assessment of clonality. This presentation will discuss a series of cases that demonstrate the utility of flow cytometry in the diagnostic workup of hematologic disorders presenting with abnormal WBC differential and incorporation of relevant criteria from the revised WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues.

Incorporation of patient-focused drug design principles is increasingly becoming essential to ensure that a new drug is commercially successful and delivers the best patient outcomes. Often, patient factors and insights are not considered or discovered until the later phases of drug development when dose form, dose strength, and route of administration are already decided. There is tremendous potential benefit of equipping formulators and other scientists with patient insights earlier in the development process so that the drug product can be designed to address the specific needs of target patient populations.

Artificial intelligence (AI) holds the promise of transforming drug discovery. By harnessing large sets of chemical and biological data, AI can accurately predict the behavior and properties of small molecules.